Extrapolation of Drug Clearance in Children ≤ 2 Years of Age from Empirical Models Using Data from Children (> 2 Years) and Adults
Abstract Background The application of modeling and simulation approaches in clinical pharmacology studies has gained momentum over the last 20 years. Objectives The objective of this study was to develop six empirical models from clearance data obtained from children aged > 2 years and adults to...
Main Author: | Iftekhar Mahmood |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2019-12-01
|
Series: | Drugs in R&D |
Online Access: | https://doi.org/10.1007/s40268-019-00291-2 |
Similar Items
-
Prediction of Clearance in Children from Adults Following Drug–Drug Interaction Studies: Application of Age-Dependent Exponent Model
by: Iftekhar Mahmood
Published: (2020-02-01) -
Prediction of Clearance of Monoclonal and Polyclonal Antibodies and Non-Antibody Proteins in Children: Application of Allometric Scaling
by: Iftekhar Mahmood
Published: (2020-08-01) -
Interspecies Scaling of Antibody–Drug Conjugates (ADC) for the Prediction of Human Clearance
by: Iftekhar Mahmood
Published: (2021-01-01) -
The rational use of available evidence before extrapolating the benefit risk ratio from adults to children
by: Janiaud, Perrine
Published: (2017) -
Longitudinal Follow-Up of Children Born Preterm: Neurodevelopment From 2 to 10 Years of Age
by: Lisette Jansen, et al.
Published: (2021-06-01)